Before characterizing the effect of LXR ligands on pancreatic cancer cell biology, which we hypothesize will restrain proliferation-related processes, we first examined LXRα and LXRβ expression in human pancreatic tumor samples and PDAC cell lines. Here, NR1H2 is linked to pancreatic neoplasm.